Further, downstream cell cycle regulators such as c-FLIP and cIAP2 regulating apoptosis mediated by TRAIL and CD95L in various cancers [41] makes c-FLIP and cIAP2 as promising target for cancer therapy. The gene discussed is TNFSF10; the disease is cancer.